SCA
BIIB icon

Salient Capital Advisors’s Biogen BIIB Stock Holding History

Salient Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,110
Closed -$850K – 215
2017
Q1 		$850K Buy
3,110
+500
+19% +$141K 0.02% 141
2016
Q4 		$740K Buy
2,610
+50
+2% +$14.8K 0.01% 145
2016
Q3 		$801K Buy
2,560
+200
+8% +$59.2K 0.02% 128
2016
Q2 		$571K Buy
2,360
+400
+20% +$105K 0.01% 160
2016
Q1 		$510K Buy
1,960
+400
+26% +$106K 0.01% 169
2015
Q4 		$478K Buy
1,560
+536
+52% +$154K 0.01% 181
2015
Q3 		$299K Buy
+1,024
New +$338K 0.01% 199

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return